Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.62 +0.07 (+4.61%)
As of: Oct 2, 2026 · 12:36 PM EDT

Transcode Therapeutics (RNAZ) Return on Assets [ROA] (2021 - 2026)

Updated

Transcode Therapeutics' Return on Assets [ROA] came in at -29.09% for Q2 2026, up 191.15 percentage points from -220.23% a year earlier but down 2.58 percentage points from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Transcode Therapeutics' Return on Assets [ROA] was -40.59%, up 228.26 percentage points from FY2024.

  • Return on Assets [ROA] carries a four-year change of +11.47 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Assets [ROA] was -268.85% in FY2024 (+36.36 pp), -305.21% in FY2023 (-183.06 pp), -122.16% in FY2022 (-70.10 pp) and -52.06% in FY2021.
  • The five-year range for quarterly Return on Assets [ROA] is -385.72% (Q3 2025) to -3.90% (Q3 2021).
  • Year-over-year, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of +76.00 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2025 (a gain of 235.36 percentage points), and the weakest in Q1 2023 (a drop of 275.06 percentage points).
  • Business Quant data shows RNAZ's Return on Assets [ROA] at -26.50% (Q1 2026), -44.00% (Q4 2025) and -385.72% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - -29.09%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -29.09%
Mar 31, 2026 -26.50%
Dec 31, 2025 -44.00%
Sep 30, 2025 -385.72%
Jun 30, 2025 -220.23%
Mar 31, 2025 -238.90%
Dec 31, 2024 -279.36%
Sep 30, 2024 -335.76%
Jun 30, 2024 -294.82%
Mar 31, 2024 -286.86%
Dec 31, 2023 -252.89%
Sep 30, 2023 -258.73%
Jun 30, 2023 -356.65%
Mar 31, 2023 -304.02%
Dec 31, 2022 -189.90%
Sep 30, 2022 -123.14%
Jun 30, 2022 -81.98%
Mar 31, 2022 -28.96%
Dec 31, 2021 -12.74%
Sep 30, 2021 -3.90%
API Access

Transcode Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RNAZ&period=max&api_key=YOUR_API_KEY